These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 24673624)
1. C-reactive protein is essential for innate resistance to pneumococcal infection. Simons JP; Loeffler JM; Al-Shawi R; Ellmerich S; Hutchinson WL; Tennent GA; Petrie A; Raynes JG; de Souza JB; Lawrence RA; Read KD; Pepys MB Immunology; 2014 Jul; 142(3):414-20. PubMed ID: 24673624 [TBL] [Abstract][Full Text] [Related]
2. Complement Activation by C-Reactive Protein Is Critical for Protection of Mice Against Pneumococcal Infection. Singh SK; Ngwa DN; Agrawal A Front Immunol; 2020; 11():1812. PubMed ID: 32903624 [TBL] [Abstract][Full Text] [Related]
3. Protection from Streptococcus pneumoniae infection by C-reactive protein and natural antibody requires complement but not Fc gamma receptors. Mold C; Rodic-Polic B; Du Clos TW J Immunol; 2002 Jun; 168(12):6375-81. PubMed ID: 12055255 [TBL] [Abstract][Full Text] [Related]
4. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae. Szalai AJ; Briles DE; Volanakis JE Infect Immun; 1996 Nov; 64(11):4850-3. PubMed ID: 8890251 [TBL] [Abstract][Full Text] [Related]
5. Treatment of Pneumococcal Infection by Using Engineered Human C-Reactive Protein in a Mouse Model. Ngwa DN; Singh SK; Gang TB; Agrawal A Front Immunol; 2020; 11():586669. PubMed ID: 33117400 [TBL] [Abstract][Full Text] [Related]
6. C-Reactive Protein-Based Strategy to Reduce Antibiotic Dosing for the Treatment of Pneumococcal Infection. Ngwa DN; Singh SK; Agrawal A Front Immunol; 2020; 11():620784. PubMed ID: 33552084 [TBL] [Abstract][Full Text] [Related]
7. Structure-Function Relationships of C-Reactive Protein in Bacterial Infection. Ngwa DN; Agrawal A Front Immunol; 2019; 10():166. PubMed ID: 30863393 [TBL] [Abstract][Full Text] [Related]
8. C-reactive protein protects mice against pneumococcal infection via both phosphocholine-dependent and phosphocholine-independent mechanisms. Gang TB; Hanley GA; Agrawal A Infect Immun; 2015 May; 83(5):1845-52. PubMed ID: 25690104 [TBL] [Abstract][Full Text] [Related]
9. C-reactive protein enhances immunity to Streptococcus pneumoniae by targeting uptake to Fc gamma R on dendritic cells. Thomas-Rudolph D; Du Clos TW; Snapper CM; Mold C J Immunol; 2007 Jun; 178(11):7283-91. PubMed ID: 17513778 [TBL] [Abstract][Full Text] [Related]
10. Blood clearance of Streptococcus pneumoniae by C-reactive protein. Horowitz J; Volanakis JE; Briles DE J Immunol; 1987 Apr; 138(8):2598-603. PubMed ID: 3559209 [TBL] [Abstract][Full Text] [Related]
11. Polymorphism of the C-reactive protein gene is associated with mortality in bacteraemia. Eklund C; Huttunen R; Syrjänen J; Laine J; Vuento R; Hurme M Scand J Infect Dis; 2006; 38(11-12):1069-73. PubMed ID: 17148079 [TBL] [Abstract][Full Text] [Related]
12. Human C-reactive protein protects mice from Streptococcus pneumoniae infection without binding to pneumococcal C-polysaccharide. Suresh MV; Singh SK; Ferguson DA; Agrawal A J Immunol; 2007 Jan; 178(2):1158-1163. PubMed ID: 17202380 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the innate immune response to Streptococcus pneumoniae infection in zebrafish. Saralahti AK; Harjula SE; Rantapero T; Uusi-Mäkelä MIE; Kaasinen M; Junno M; Piippo H; Nykter M; Lohi O; Rounioja S; Parikka M; Rämet M PLoS Genet; 2023 Jan; 19(1):e1010586. PubMed ID: 36622851 [TBL] [Abstract][Full Text] [Related]
14. The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. Ali YM; Lynch NJ; Haleem KS; Fujita T; Endo Y; Hansen S; Holmskov U; Takahashi K; Stahl GL; Dudler T; Girija UV; Wallis R; Kadioglu A; Stover CM; Andrew PW; Schwaeble WJ PLoS Pathog; 2012; 8(7):e1002793. PubMed ID: 22792067 [TBL] [Abstract][Full Text] [Related]
15. Role of the property of C-reactive protein to activate the classical pathway of complement in protecting mice from pneumococcal infection. Suresh MV; Singh SK; Ferguson DA; Agrawal A J Immunol; 2006 Apr; 176(7):4369-74. PubMed ID: 16547275 [TBL] [Abstract][Full Text] [Related]
16. Review of phosphocholine substituents on bacterial pathogen glycans: synthesis, structures and interactions with host proteins. Young NM; Foote SJ; Wakarchuk WW Mol Immunol; 2013 Dec; 56(4):563-73. PubMed ID: 23911414 [TBL] [Abstract][Full Text] [Related]
17. The protective function of human C-reactive protein in mouse models of Streptococcus pneumoniae infection. Agrawal A; Suresh MV; Singh SK; Ferguson DA Endocr Metab Immune Disord Drug Targets; 2008 Dec; 8(4):231-7. PubMed ID: 19075776 [TBL] [Abstract][Full Text] [Related]
18. C-reactive protein reactivity with complement and effects on phagocytosis. Mold C; Du Clos TW; Nakayama S; Edwards KM; Gewurz H Ann N Y Acad Sci; 1982; 389():251-62. PubMed ID: 7046579 [TBL] [Abstract][Full Text] [Related]
19. Antipneumococcal effects of C-reactive protein and monoclonal antibodies to pneumococcal cell wall and capsular antigens. Briles DE; Forman C; Horowitz JC; Volanakis JE; Benjamin WH; McDaniel LS; Eldridge J; Brooks J Infect Immun; 1989 May; 57(5):1457-64. PubMed ID: 2707854 [TBL] [Abstract][Full Text] [Related]
20. Influenza A virus-induced release of interleukin-10 inhibits the anti-microbial activities of invariant natural killer T cells during invasive pneumococcal superinfection. Barthelemy A; Ivanov S; Fontaine J; Soulard D; Bouabe H; Paget C; Faveeuw C; Trottein F Mucosal Immunol; 2017 Mar; 10(2):460-469. PubMed ID: 27220813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]